Stay updated with breaking news from Nasdaq Clsd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clearside Biomedical, Inc. (NASDAQ:CLSD – Free Report) – HC Wainwright dropped their Q3 2023 earnings per share (EPS) estimates for Clearside Biomedical in a note issued to investors on Tuesday, August 15th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.16) per share for the quarter, down from their […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has received a consensus recommendation of “Buy” from the five analysts that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have issued ratings on the stock in the last year […]
Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “market outperform” rating reissued by stock analysts at JMP Securities in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $5.00 price target on the stock. JMP Securities’ target price indicates a potential upside of 429.10% from the […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has earned a consensus rating of “Buy” from the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have updated their coverage on the stock […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 626,100 shares, an increase of 10.2% from the May 15th total of 568,400 shares. Currently, 1.2% of the shares of the company are sold […]